Generated by DeepSeek V3.2| phosphocreatine | |
|---|---|
| Name | Phosphocreatine |
| IUPACName | 2-[Methyl-(N'-phosphonocarbamimidoyl)amino]acetic acid |
| OtherNames | Creatine phosphate, PCr |
phosphocreatine. It is a phosphorylated creatine molecule that serves as a rapidly mobilizable reserve of high-energy phosphates in skeletal muscle, the brain, and other tissues. This biochemical plays a critical role in maintaining cellular adenosine triphosphate levels during periods of intense metabolic demand. The compound is central to the phosphagen system, providing an immediate buffer for ATP regeneration.
The molecule consists of a creatine backbone linked to a phosphate group via a high-energy N-P bond. This structure is analogous to other high-energy phosphate compounds like adenosine triphosphate but is more stable in the cellular environment. Its synthesis is catalyzed by the enzyme creatine kinase, a reaction that is readily reversible depending on the energy state of the cell. The compound's properties allow it to act as a spatial and temporal buffer, shuttling high-energy phosphates from sites of ATP production, like the mitochondria, to sites of ATP utilization, such as the myofibrils.
Biosynthesis occurs primarily in the liver, kidneys, and pancreas, where the precursor amino acids glycine, arginine, and methionine are combined. The final phosphorylation step is mediated by creatine kinase, an enzyme with several tissue-specific isozymes including the mitochondrial form CKMT2 and the muscle-specific CKM. Regulation is tightly coupled to cellular energy charge; high levels of adenosine diphosphate stimulate the kinase reaction to regenerate ATP, while high ATP levels favor phosphocreatine synthesis. Hormonal influences, such as those from the thyroid gland, can also modulate overall creatine pool sizes.
Its primary role is to rapidly rephosphorylate adenosine diphosphate to adenosine triphosphate during the initial seconds of intense muscle contraction, a process fundamental to activities like sprinting or weightlifting. This reaction is catalyzed by creatine kinase and is a cornerstone of the phosphagen system. In tissues with high and fluctuating energy demands, such as cardiac muscle and neurons, it acts as an essential energy buffer, preventing large swings in ADP concentration. The creatine kinase/phosphocreatine circuit is also vital for intracellular energy transport, facilitating the movement of high-energy phosphates from the mitochondria to the cytosol.
Abnormal levels are implicated in various myopathies and neurodegenerative disorders; deficiencies can be seen in creatine deficiency syndromes linked to mutations in genes like GAMT and SLC6A8. In cardiology, its depletion is a marker of myocardial ischemia and is assessed using techniques like magnetic resonance spectroscopy. Supplementation with creatine monohydrate has been studied for enhancing performance in athletics and potentially mitigating symptoms in conditions like Parkinson's disease and Huntington's disease. Research at institutions like the National Institutes of Health continues to explore its therapeutic potential.
Concentration is non-invasively measured in vivo using phosphorus-31 magnetic resonance spectroscopy, a technique pioneered at centers like the University of Oxford and Massachusetts General Hospital. In vitro, analytical methods include high-performance liquid chromatography and enzymatic assays coupled with spectrophotometry. These measurements are crucial in sports science research at organizations like the Australian Institute of Sport and for diagnosing metabolic disorders in clinical settings such as the Mayo Clinic.
Category:Phosphagen